Chronic Fatigue Syndrome Trial, Recruiting (NCT07491315)

Chronic Fatigue Syndrome Trial, Recruiting NCT07491315 Sponsor: Hôpital Européen Marseille Condition: Chronic Fatigue Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT07491315 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Fatigue Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
If you have Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS): you must have been officially diagnosed with ME/CFS using a specific set of medical guidelines called the International Consensus Criteria (ICC) from 2011
If you have a heart condition: you must have been referred for an exercise test in a cardiology (heart) department for reasons such as palpitations, high blood pressure, shortness of breath during activity, chest pain, or coronary artery disease, AND you must have been experiencing moderate to severe tiredness (rated more than 3 out of 10) in the last 8 days, AND you must not have a diagnosis of ME/CFS
You must be able to use a computer or digital device to fill in online questionnaires
You must be willing and able to give written consent to take part

Who may not be able to join:

Women who are pregnant or breastfeeding
People who are currently imprisoned or detained by a court or official authority
People who are under a legal guardianship order or who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0413428351

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07491315

Sponsor: Hôpital Européen Marseille

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Fatigue Syndrome

Trial contact: 0413428351

More information: https://clinicaltrials.gov/study/NCT07491315

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
If you have Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS): you must have been officially diagnosed with ME/CFS using a specific set of medical guidelines called the International Consensus Criteria (ICC) from 2011
If you have a heart condition: you must have been referred for an exercise test in a cardiology (heart) department for reasons such as palpitations, high blood pressure, shortness of breath during activity, chest pain, or coronary artery disease, AND you must have been experiencing moderate to severe tiredness (rated more than 3 out of 10) in the last 8 days, AND you must not have a diagnosis of ME/CFS
You must be able to use a computer or digital device to fill in online questionnaires
You must be willing and able to give written consent to take part

Who may not be able to join:

Women who are pregnant or breastfeeding
People who are currently imprisoned or detained by a court or official authority
People who are under a legal guardianship order or who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hôpital Européen Marseille

Registry

ClinicalTrials.gov

Start date

24 June 2025

Est. completion

24 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Time to onset of symptoms after completion of the exercise test on an ergocycle in both groups.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov